181 related articles for article (PubMed ID: 29631526)
1. Does eosinophilia and neutrophil to lymphocyte ratio affect hospital re-admission in cases of COPD exacerbation?
Çoban Ağca M; Aksoy E; Duman D; Özmen İ; Yıldırım E; Güngör S; Durmuş N; Aka Aktürk Ü; Saltürk C; Tepetam FM; Karakurt Z
Tuberk Toraks; 2017 Dec; 65(4):282-290. PubMed ID: 29631526
[TBL] [Abstract][Full Text] [Related]
2. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.
Acartürk Tunçay E; Karakurt Z; Aksoy E; Saltürk C; Gungor S; Ciftaslan N; Irmak İ; Yavuz D; Ocakli B; Adıgüzel N
Int J Chron Obstruct Pulmon Dis; 2017; 12():3361-3370. PubMed ID: 29200843
[TBL] [Abstract][Full Text] [Related]
4. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?
Saltürk C; Karakurt Z; Adiguzel N; Kargin F; Sari R; Celik ME; Takir HB; Tuncay E; Sogukpinar O; Ciftaslan N; Mocin O; Gungor G; Oztas S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1837-46. PubMed ID: 26392758
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
[TBL] [Abstract][Full Text] [Related]
6. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.
Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.
Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M
Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279
[TBL] [Abstract][Full Text] [Related]
10. A new predictor to determine the exacerbation and treatment of chronic obstructive pulmonary disease: eosinophil/neutrophil ratio.
Yakar Hİ; Kanbay A
Tuberk Toraks; 2020 Sep; 68(3):260-267. PubMed ID: 33295724
[TBL] [Abstract][Full Text] [Related]
11. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease.
Rahimirad S; Ghaffary MR; Rahimirad MH; Rashidi F
Tuberk Toraks; 2017 Mar; 65(1):25-31. PubMed ID: 28621246
[TBL] [Abstract][Full Text] [Related]
12. A Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease.
Aksoy E; Güngör S; Ağca MÇ; Özmen İ; Duman D; Koçak ND; Aktürk ÜA; Tunçay E; Saltürk C; Yalçınsoy M; Ocaklı B; Karakurt Z
Turk Thorac J; 2018 Oct; 19(4):193-200. PubMed ID: 30322438
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD.
Kandemir Y; Doğan NÖ; Yaka E; Pekdemir M; Yılmaz S
Am J Emerg Med; 2021 Jul; 45():237-241. PubMed ID: 33041140
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients.
El-Gazzar AG; Kamel MH; Elbahnasy OKM; El-Naggar ME
Expert Rev Respir Med; 2020 Jan; 14(1):111-116. PubMed ID: 31577911
[No Abstract] [Full Text] [Related]
15. Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation.
Chen TT; Lee KY; Chang JH; Chung CL; Tran HM; Manullang A; Ho SC; Chen KY; Tseng CH; Wu SM; Chuang HC
Ann Med; 2023; 55(2):2285924. PubMed ID: 38065676
[TBL] [Abstract][Full Text] [Related]
16. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Feng X; Xiao H; Duan Y; Li Q; Ou X
Int J Chron Obstruct Pulmon Dis; 2023; 18():1219-1230. PubMed ID: 37337582
[TBL] [Abstract][Full Text] [Related]
19. Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.
Bafadhel M; Greening NJ; Harvey-Dunstan TC; Williams JE; Morgan MD; Brightling CE; Hussain SF; Pavord ID; Singh SJ; Steiner MC
Chest; 2016 Aug; 150(2):320-8. PubMed ID: 26851799
[TBL] [Abstract][Full Text] [Related]
20. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.
Pascual-González Y; López-Sánchez M; Dorca J; Santos S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3651-3662. PubMed ID: 30464448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
